Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.61
-0.70 (-4.89%)
At close: Nov 13, 2026, 4:00 PM EST
13.68
+0.07 (0.51%)
After-hours: Nov 13, 2026, 7:30 PM EST
Korro Bio Employees
Korro Bio had 58 employees as of September 30, 2026. The number of employees decreased by 29 or 33.33% compared to the same quarter last year. That makes Korro Bio the 34,408th largest employer in the world and 4,558th in the United States.
Employees
58
Change (1Y)
-29
Growth (1Y)
-33.33%
Revenue / Employee
$22,276
Profits / Employee
-$1,829,845
Market Cap
186.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 58 | -29 | -33.33% | 58 | 0 |
| Jun 30, 2026 | 57 | -35 | -38.04% | 57 | 0 |
| Mar 31, 2026 | 49 | -63 | -56.25% | 49 | 0 |
| Dec 31, 2025 | 58 | -46 | -44.23% | 58 | 0 |
| Sep 30, 2025 | 87 | -8 | -8.42% | 87 | 0 |
| Jun 30, 2025 | 92 | 0 | - | 92 | 0 |
| Mar 31, 2025 | 112 | 18 | 19.15% | 112 | 0 |
| Dec 31, 2024 | 104 | 2 | 1.96% | 104 | 0 |
| Sep 30, 2024 | 95 | -1 | -1.04% | 95 | 0 |
| Jun 30, 2024 | 92 | 4 | 4.55% | 92 | 0 |
| Mar 31, 2024 | 94 | 6 | 6.82% | 94 | 0 |
| Dec 31, 2023 | 102 | - | - | 101 | 1 |
| Sep 30, 2023 | 96 | - | - | 95 | 1 |
| Jun 30, 2023 | 88 | - | - | 88 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Artiva Biotherapeutics | 134 |
| BridgeBio Oncology Therapeutics | 88 |
| Keros Therapeutics | 87 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| InflaRx | 65 |
KRRO News
- 1 day ago - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Korro to Present at the 2026 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 9 days ago - Korro Bio Inc trading resumes - TheFly
- 9 days ago - Korro Bio Inc trading halted, volatility trading pause - TheFly
- 9 days ago - Korro Bio reports Q3 EPS (98c), consensus ($1.26) - TheFly
- 9 days ago - Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 days ago - Korro Bio Quarterly report: Q3 2026 - Filings
- 9 days ago - Korro Bio Earnings release: Q3 2026 - Filings